Skip subpage navigation
View the following policies and guidance about Depleted Uranium exposure.
| File | Description |
| DHA-AI: Air Force Medical Service Depleted Uranium Medical Management Implementation Instructions | Air Force instructions for managing patients with potential exposure to DU |
| Memorandum: #HA Policy: 04-004, Department of Defense Deployment Biomonitoring Policy and Approved Bioassays for Depleted Uranium and Lead | The Department has developed criteria for the approval of bioassays to support deployment operations (Attachment 2). Bioassays for Depleted Uranium and lead (Attachments 3 and 4) are approved for use at this time to assess human exposures during or after deployment and combat operations. |
| Instruction: #DoD Instruction Number 6055.08, DoD Instruction Number 6055.08: Occupational Ionizing Radiation Protection Program | Implement Occupational Safety and Health Administration (OSHA) ionizing radiation standards pursuant to subpart 1910.1096 of title 29, Code of Federal Regulations (CFR). |
| Guideline: Handling Procedures for Equipment Contaminated with Depleted Uranium or Radioactive Commodities | Provides specific guidance on the handling of U.S. and foreign equipment that may have been contaminated with radioactive materials as a result of DU munitions/armor or damaged radioactive commodities. |
| Instruction: Initial Management of Irradiated or Radioactively Contaminated Personnel | Provides direction to the Medical Department, civilian medical personnel of the naval services, and Navy and Marine Corps commands for the initial exposure assessment, management, and treatment of individuals who are irradiated or externally or internally radioactively contaminated. References (a) through (d) provide additional guidance. |
| Memorandum: Medical Management of Army Personnel Exposed to Depleted Uranium | All personnel with actual or potential exposures to DU will be identified, assessed, treated (if needed), and assigned a potential exposure level (I, II, or Ill). |
| Memorandum: Operation Iraqi Freedom Depleted Uranium Medical Management | This memo directs the Services to report their DU urine bioassay results |
| Memorandum: #HA-Policy 12-001, Operation IRAQI FREEDOM/Operation NEW DAWN Depleted Uranium Bioassay Results - 16th Semi-Annual Report and Policy on Future Data Submissions | This policy changes the requirement for the reporting off data from the Services' DU urine biomonitoring programs. |
| Memorandum: #HA Policy: 03-012, Policy for the Operation Iraqi Freedom Depleted Uranium (DU) Medical Management | This policy outlines the military Services responsibilities for the DU Medical Management program. |
| Directive: Radioactive Materials Management | This instruction implements Air Force Policy Directive (AFPD) 40-2, Radioactive Materials (Non-Nuclear Weapons) IAW Title 42 of the United States Code (42 U.S.C.), Chapter 23, Development and Control of Atomic Energy; Title 10 of the Code of Federal Regulations (10 CFR) Chapter I Nuclear Regulatory Commission; and the conditions of the US Air Force Master Materials License (MML) issued by the US Nuclear Regulatory Commission (NRC) and managed by the US Air Force Radioisotope Committee (RIC). |
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: July 11, 2023